Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Idun Pharmaceuticals
company
About
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $22.80M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1993
- Number Of Employee
- 51 - 100
- Operating Status
- Active
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$49.80M
Idun Pharmaceuticals has raised a total of
$49.80M
in funding over 2 rounds. Their latest funding was raised on
Jun 20, 2004 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2004 | Series Unknown | $27M | 1 | — | — | Detail |
| Dec 9, 2002 | Series A | $22.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Idun Pharmaceuticals is funded by 2 investors.
Pacific Rim Ventures
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pacific Rim Ventures
|
— | Series Unknown |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
